‘Chronic Lyme’ Patients Are Getting Left Behind, but Long COVID Research Is Sparking New Hope

  • 📰 iamwellandgood
  • ⏱ Reading Time:
  • 78 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 35%
  • Publisher: 53%

United States Headlines News

United States Latest News,United States Headlines

People with chronic Lyme disease (or PTLDS) are understudied and have limited treatment options, but the tide is turning post-COVID.

“If I took my dog on a 20-minute walk, I was in bed for the rest of the day,” she says. “Forget about going to the gym, despite the fact that I had been an athlete growing up.”, confusion. “I couldn't remember my friends' names,” Adams says. “My best friend would say to me, ‘where do you want to go to dinner?’ And I had to have her repeat that to me five times before I understood the context of the question.

Too often, these patients are getting left behind by the health care system. People with very real but hard-to-diagnose post-Lyme symptoms often end up seeing doctors who are “operating outside of insurance and outside of many of our established standards of care,” says Tal. For many folks who suspect they have lingering Lyme symptoms, “this is the only option,” she adds. “We have these big cracks in the medical system, and people are falling through.

“Although adequate studies have not been done in people, if you speak to a vet about whether or not tick pathogens persist, they will tell you absolutely. Yes. All the time they see it,” Putrino says.. You only need the second test if the first test is positive or inconclusive. But this process isn’t perfect, and false positives and negatives are known to happen, the CDC notes.

For five years, Adams took supplements and cycled through antibiotics. “I was feeling better, but I was still sick, and I had the symptoms to prove it,” she says. Antibiotics, of course, slaughter both bad and good bacteria, leading to side effects .

As tick-borne diseases continue to spread to new parts of the country, scientists have also made progress on a number ofTal’s group at MIT is researching immune markers to predict who will develop chronic symptoms after a Lyme infection . They hope this will help improve the design of future clinical trials for chronic Lyme treatments and help people access these treatments earlier in their illness, before symptoms become severe.

Source: Healthcare Press (healthcarepress.net)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 462. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Lawmakers Seek Easier Access to Injections and IVs for Chronic Illness, Cancer Patients'If they could just get it at their local doctor's office, it would make a lot more sense.'
Source: denverwestword - 🏆 315. / 61 Read more »

Why COVID patients who could most benefit from Paxlovid still aren’t getting itShrunken confidence in government health programs is one reason the drug isn’t reaching those who need it.
Source: mercnews - 🏆 88. / 68 Read more »

The continuing fight for Long COVID and Myalgic Encephalomyelitis patientsBilly Hanlon, who has been living with ME/CFS since 2017, spoke with the Amsterdam News in a Q&A about Long COVID.
Source: NYAmNews - 🏆 269. / 63 Read more »

Lyme disease in dogs: What dog owners should knowAs Lyme disease cases rise in the U.S., humans are not the only ones at risk. Veterinarians with the Virginia-Maryland College of Veterinary Medicine say dogs are increasingly vulnerable to this tick-borne illness.
Source: physorg_com - 🏆 388. / 55 Read more »

Potential new treatment path for lasting Lyme disease symptomsResearchers have identified a potential new treatment for persistent neurological symptoms of Lyme disease, commonly seen even after antibiotic use. The study found that fibroblast growth factor receptor inhibitors, previously studied in cancer, significantly reduced inflammation and cell death in infected brain and nerve tissues.
Source: ScienceDaily - 🏆 452. / 53 Read more »

How Cancer Research Is Revolutionizing Lyme Disease TreatmentScience, Space and Technology News 2024
Source: SciTechDaily1 - 🏆 84. / 68 Read more »